Recombinant methionyl human stem cell factor | |
---|---|
Trade Name | |
Orphan Indication | Primary bone marrow failure |
USA Market Approval | USA |
USA Designation Date | 1995-11-22 00:00:00 |
Sponsor | Amgen, Inc.;One Amgen Center Drive;Thousand Oaks, California, 91320 |